centre for comparative genomics

Daniel Ricciardo’s Aston Martin to boost Murdoch-based MND research

March 21st, 2018

WA-raised Formula One driver Daniel Ricciardo will personally auction off his special edition Red Bull Aston Martin Roadster tomorrow evening ahead of the Australian Grand Prix in Melbourne. Funds raised (above the reserve value) from the auction will be poured into the search for a treatment for Motor Neuron Disease (MND), with the proceeds earmarked for Murdoch’s […]

+ Find out more

Funding boost brings new hope for rare disease sufferers

November 28th, 2017

Researchers at Murdoch University have been awarded significant federal funding to help develop genetic therapies for rare diseases. Professor Steve Wilton will lead the project, which has received $800,000 from the Australian Government’s National Health and Medical Research Council (NHMRC) over the next three years.

+ Find out more

Tribute to inspirational student at Murdoch research showcase

November 14th, 2017

Emerging researcher: Tamara Hourani with her supervisor Dr Garth Maker (left) and Conor Murphy

A new award that honours the incredible life and achievements of late Murdoch University student Conor Murphy, has been presented to a high-achieving honours student.

+ Find out more

Major project funding heralds new frontiers in innovative health futures

October 26th, 2017

A major project is now underway at Murdoch University to transform the way new therapeutic drugs are tested, giving the community and patients a greater say in treatment. The project has received significant funding, including a grant from MTPConnect and a long list of medical sector partners, including Telethon Kids Institute as a key cash partner.

+ Find out more

Digital disruption the key to future healthcare

October 11th, 2017

Professor Matthew Bellgard will present the prestigious Dennis Moore Oration for the annual Australian Computer Society in Western Australia, speaking on how we need to embrace digital disruption to advance clinical research.

+ Find out more

Work begins on genetic treatment for diabetes and obesity

July 18th, 2017

A Murdoch researcher is embarking on a revolutionary new synthetic RNA therapy to treat Type-2 Diabetes and obesity. Dr Rakesh Veedu will work on the project with lead investigator Dr Harendra Parekh from the University of Queensland and Chief Research Officer at PMI, and Professor Grant Ramm at the QIMR Berghofer Medical Research Institute. The research program is funded by Preveceutical Medical Inc over the next four years.

+ Find out more

Hope for Duchenne sufferers around the world

April 27th, 2017

16-year-old Billy Ellsworth is still walking thanks to Western Australian researchers who developed the first drug to address the underlying genetic defect of Duchenne, and the first of its type to be approved by the US Food and Drug Administration.

+ Find out more

Murdoch’s five finalists in IT awards

April 14th, 2017

Murdoch University has five finalists in the 2017 WAITTA (Western Australia Information Technology and Telecommunications Alliance) INCITE Awards. The Centre for Comparative Genomics (CCG) has been made a finalist in the ‘Most Impactful Social Benefit’ category for their Rare Disease Registry Framework (RDRF), an online patient registry that connects health stakeholders within disease communities. The […]

+ Find out more

Murdoch professors receive Australia Day Honours

January 31st, 2017

Professor Bittles was one of two professors honoured on Australia Day

The life works of two Murdoch professors have recognised with prestigious honours during the 2017 Australia Day Awards.

+ Find out more

Government awards Murdoch $1.25m for drugs research  

December 6th, 2016

Professor Elizabeth Phillips, Director of the Centre for Clinical Pharmacology and Infectious Diseases at IIID

Researchers at Murdoch University have been awarded $1.25million in government funding to help reduce the number of people who experience adverse drug reactions (ADR).

+ Find out more